Study shows how EU safety legislation has affected UK vapers

NewsGuard 100/100 Score

Vapers have been largely reassured by recent EU safety regulations, but some have been pushed to the black market for stronger hits - according to new research from the University of East Anglia.

Researchers studied reactions to vaping legislation. The EU’s Tobacco Products Directive (TPD) was introduced in 2017 - to ensure safety, provide consumer information and deter young people who had never smoked before, from trying it.

The regulations include things like a maximum volume for liquid, limits on nicotine concentration, and the need for health warning labels. The legislation also prohibits specific hazardous ingredients.

The study reveals how, from a consumer perspective, future regulation should not further restrict liquid or tank volumes and nicotine concentration, but should focus on ensuring e-liquid product safety.

Switching to vaping is now the most popular way for people to stop smoking in the UK. Studies have shown that while vape liquid can contain potentially harmful compounds, it is much safer than smoking tobacco. But regulation of e-cigarettes varies considerably around the world, from no legislation at all in around half of countries, to total bans in 29 countries.”

Dr Emma Ward, Lead researcher, UEA’s Norwich Medical School

Prof Caitlin Notley, also from UEA’s Norwich Medical School, said: “There have been significant concerns from consumers, industry, and even some in the scientific community about the potential negative impact of the TPD rules.

“We wanted to find out how consumers perceived and experienced the regulations.”

The study is the first to investigate consumers’ views and experiences of the TPD regulations. The research team looked at 160 interviews and surveys as part of a wider study into e-cigarette use.

Dr Ward said: “We found that awareness about safety legislation was not universal but on the whole, vapers were reassured by manufacturing regulations and requirements for ingredients labels.

“Some of the participants felt the regulations led to more plastic waste, because it meant they needed to use smaller bottles of e-liquid, with more packaging.

“But the most worrying thing that we found was that the restrictions caused some people to buy higher strength e-liquids and prohibited components on the black market via countries where regulations do not apply such as China and the US - potentially putting their safety at risk.”

“A large proportion of participants didn’t know much about the EU regulations and many said they wanted regulations which were already in place.

“Public health bodies, Stop Smoking Services, and healthcare professionals should consider raising awareness about the regulations to smokers, to offer reassurance about vaping products and e-liquid ingredients. This could help more smokers switch to vaping.

“Harm reduction messages on packaging, comparing e-cigarettes to tobacco could also nudge smokers to switch to less harmful vaping,” she added.

All of this is particularly important right now during the Covid-19 pandemic. Since completely switching from smoking to vaping improves cardiovascular and respiratory conditions, smokers who switch to vaping might be expected to have a better prognosis if infected by Covid-19.”

Prof Caitlin Notley, UEA’s Norwich Medical School

The research was led by UEA, in collaboration with London South Bank University and the University of Leicester. It was funded by Cancer Research UK.

‘A Qualitative Exploration of Consumers’ Perceived Impacts, Behavioral Reactions, and Future Reflections of the EU Tobacco Products Directive (2017) as Applied to Electronic Cigarettes’ is published in the journal Tobacco Use Insights on Friday, June 19, 2020.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis